An inaccurate statement that President Trump made during a March 19 news briefing — that the malaria drug hydroxychloroquine had been approved as a COVID-19 treatment — demonstrates how skeptical journalists should remain when covering the unfolding story about treatments and preventative measures.
While there are more than 85 trials for vaccines and treatments underway for COVID-19, scientists don’t expect them to be available to the public soon, despite what some headlines suggest. Continue reading
President Donald Trump has pledged to unveil a new plan to repeal and replace the ACA – but we haven’t seen it, and it’s not clear that we ever will. If the president does announce a plan, it’s to campaign on in 2020, not to try to enact before the November elections with a Democratic-controlled House and a divided Senate.
There’s no way to know how the Ukraine scandal will factor into health care and domestic policy. Trump may focus on impeachment and politics to the exclusion of health care – or he may try to change the subject with some kind of health platform. Continue reading
The Trump administration has been talking tough on drug prices for many months and, of course, pharmaceutical companies and other organizations have pushed back because they mostly oppose controls on the free market for prescription drugs.
For health care journalists covering these proposals, it’s essential to remain skeptical of any group that offers support or opposition and, as always, follow the money. Continue reading
Think the only big lawsuit pending on the Affordable Care Act is the Texas fight over whether the whole law is unconstitutional? Think again.
Several lawsuits are still working their way through the courts involving the unpaid cost-sharing reduction (CSR) subsidies, and risk corridor payments. Potentially, the Trump administration could be forced to pay insurers billions of dollars. (Paul Demko has reported on this extensively for Politico, and this post cribs shamelessly — but gratefully — from his knowledge.) Continue reading
President Trump, along with immigration opponents, repeatedly assert that immigrants are bringing infectious diseases to the U.S., but never provide any data to back up their claims.
That is because virtually every public health expert says there isn’t any evidence that this is the case. Continue reading
The Action for Dental Health Act of 2018 has been described as a modest piece of legislation.
But supporters have also hailed the measure as a heartening acknowledgment by federal legislators of the need to respond to the long-unmet dental needs of millions of Americans. In a rare show of bipartisanship, Congress last week passed the legislation, which is headed to President Trump’s desk to be signed into law. Continue reading